Recently, Dr. Sun Yimin, President of CapitalBio Technology, along with Dr. Li Yanze, Assistant President, visited Kyrgyzstan to hold a working meeting with officials at the Chinese Embassy in Kyrgyzstan. During the same period, at the 19th MedExpo Kyrgyzstan, Minister of Health of Kyrgyzstan, Kanatbek Temirbekovich Bekboyev, visited the CapitalBio Technology booth and held in-depth discussions with Dr. Sun and his delegation, further advancing the construction of the Kyrgyzstan National Precision Medicine Center.
As the joint construction of the Belt and Road Initiative enters a new stage of high-quality development, CapitalBio Technology is committed to seizing this opportunity and working closely with Kyrgyz partners to steadfastly promote high-quality cooperation under the BRI framework.
Development of Transcriptome Sequencing TechnologyApril 4, 2023Transcriptome refers to the total sum of all expressed genes in a specific cell under specific functional conditions, which includes all transcript information of a cell. Typically, transcriptome anal...view
Microbiome Sequencing: The Next Frontier in Personalized MedicineJune 26, 2023In the past few decades, we have witnessed remarkable advancements in medical technology that have revolutionized the way we approach healthcare. One of the most promising frontiers in this field is m...view
What is IVF Preimplantation Genetic Testing (PGT)?June 20, 20221. What is Preimplantation Genetic Testing (PGT)?Preimplantation genetic testing (PGT) is a method of screening some cells from an embryo and detecting related genetic and chromosomal disorders. This ...view
What Is Chromosome Karyotype Analysis?April 4, 2023Chromosome karyotype analysis is a technique that traditionally involves observing the morphology of chromosomes. In recent years, fluorescence in situ hybridization technology has been used to detect...view